S. Krulewicz

发表

Differences in Medication Adherence and Healthcare Resource Utilization Patterns

D. Sheehan, M. Eaddy, J. Kraus, 2008, CNS drugs.

Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

S. Kutcher, K. Wagner, G. Emslie, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder.

K. Wagner, J. Horrigan, S. Krulewicz, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Treatment patterns, outcomes and clinical characteristics in advanced renal cell carcinoma: a real-world US study.

Frank X Liu, A. Leith, R. Kim, 2020, Future oncology.

Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial

J. Larkin, T. Choueiri, E. Lam, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine

M. Thase, C. Nemeroff, M. Owens, 2008, Neuropsychopharmacology.

Factors Associated with Developing Neurocognitive Adverse Events in Patients Receiving Lorlatinib After Progression on Other Targeted Therapies.

B. Yeap, A. Abbattista, J. Gainor, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-Merkel Melanoma and Cutaneous Malignancies

Liu, Frank, R. Kim, 2021 .

Real‐World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR‐Merkel

Frank X Liu, C. L. Cowey, A. Bhanegaonkar, 2021, The oncologist.

Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.

J. Davidson, M. Stein, E. Foa, 2008, The Journal of clinical psychiatry.

Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.

A. Metz, A. Apter, S. Krulewicz, 2006, Journal of child and adolescent psychopharmacology.

Childhood abuse and treatment response in patients with irritable bowel syndrome: a post‐hoc analysis of a 12‐week, randomized, double‐blind, placebo‐controlled trial of paroxetine controlled release

A. Patkar, C. Pae, P. Mannelli, 2009, Journal of clinical pharmacy and therapeutics.

History of depressive and/or anxiety disorders as a predictor of treatment response: A post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia

P. Masand, A. Patkar, C. Pae, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release

P. Masand, A. Patkar, Changsu Han, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study.

P. Masand, A. Patkar, Changsu Han, 2008, Primary care companion to the Journal of clinical psychiatry.

The Kutcher Adolescent Depression Scale: assessment of its evaluative properties over the course of an 8-week pediatric pharmacotherapy trial.

S. Kutcher, S. Krulewicz, S. Brooks, 2003, Journal of child and adolescent psychopharmacology.

Effects of Paroxetine and Venlafaxine XR on Heart Rate Variability in Depression

J. Davidson, C. Nemeroff, M. Owens, 2005, Journal of clinical psychopharmacology.

A randomized, controlled, trial of controlled release paroxetine in fibromyalgia.

P. Masand, A. Patkar, Wei Jiang, 2007, The American journal of medicine.

A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome.

P. Masand, A. Patkar, C. Pae, 2009, Psychosomatics.

Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.

Frank X Liu, C. L. Cowey, A. Bhanegaonkar, 2021, Future oncology.

Reply to the Letter to the Editor From Zhao et al.

B. Yeap, I. Dagogo-Jack, S. Krulewicz, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Real-World Outcomes Among US Veterans Health Administration Patients Newly Diagnosed with Metastatic Renal Cell Carcinoma and Treated with First-Line Monotherapy

A. Bhanegaonkar, R. Kim, V. Kasturi, 2021, Advances in Therapy.

P. Masand, A. Patkar, Changsu Han, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.